focus -WSS

focus

author：entertainment 2025-09-03 07:56:43 - browse：411

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Hey, doctors: Don't be no

entertainment

explore

WSS

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Prosthetic arm enables patients to feel the objects they grip

Biden White House, tech companies launch new safeguards around emerging AI technology

Do more moles mean more problems? Not so, says new study

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Antibiotic resistance nearly killed me, so I'm raising awareness of it

entertainment

focus

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'The View' co

Virginia high school admissions case could be legal follow

What is the Turing Test that determines if computers can think?

Walensky prepares to leave CDC — and Congress — behind

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

BioMarin wins approval for gene therapy to treat hemophilia A

What is the Turing Test that determines if computers can think?

Medical leaders decry Supreme Court decision on affirmative action

Addiction doctors spar with methadone clinics over legislation

hotspot

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

A new deal aims to ramp up use of AI in rehab care decisions

Prosthetic arm enables patients to feel the objects they grip

How Brent Saunders' Allergan experiment failed

Scientists successfully use ultrasound imaging to map brain activity

What is the Turing Test that determines if computers can think?

explore

entertainment

explore

hotspot